Epinephrine vs Norepinephrine as the Initial Vasoactive Agent in Pediatric Septic Shock: A Feasibility Randomized Controlled Trial for Recruitment Rates and Protocol Adherence, the Epinephrine vs Norepinephrine in Pediatric Septic Shock Trial
Nataraj R, Dalal P, Vijayaraghavan BKT, Venkatachalam P, Kumar V, Lakshmanan L, <i>et al</i>. Epinephrine vs Norepinephrine as the Initial Vasoactive Agent in Pediatric Septic Shock: A Feasibility Randomized Controlled Trial for Recruitment Rates and Protocol Adherence, the Epinephrine vs Norepinephrine in Pediatric Septic Shock Trial. Indian J Crit Care Med 2025;29(9):737-745.
Authors
- Priyavarthini Venkatachalam
- Suchitra Ranjit (ORCID: https://orcid.org/0000-0002-2943-2670)
- Parth Dalal (ORCID: https://orcid.org/0000-0001-8847-9973)
- Niranjan Kissoon (ORCID: https://orcid.org/0000-0002-7853-4075)
Institutions
- Apollo Hospitals (IN)
- University Children's Hospital Zurich (CH)
- George Institute for Global Health (IN)
- B.C. Women's Hospital & Health Centre (CA)
Publication Details
- Journal
- Indian Journal of Critical Care Medicine
- Published
- 2025-09-19
- DOI
- https://doi.org/10.5005/jp-journals-10071-25043
- Citations
- 2
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71